Table 6 Comparison of clinical parameters analyzed and particular genotypes of the -197G > A IL-17 polymorphism in women with osteoporosis

T-score

−2.93 ± 0.73

−3.30 ± 0.67

−2.97 ± 0.75

Z-score

−1.50 ± 0.66

−1.62 ± 0.50

−1.40 ± 0.72

Body mass (kg)

64.11 ± 8.13

60.07 ± 9.22

59.68 ± 8.47

Height (cm)

163.61 ± 4.89

160.77 ± 4.90

157.82 ± 5.13

Body mass index (kg/m²)

25.92 ± 3.62

23.30 ± 4.11

22.61 ± 3.73

Age

60.07 ± 7.90

50.32 ± 8.18

52.13 ± 8.36

Birth weight

3192.68 ± 493.06

3062.23 ± 443.24

2878.24 ± 506.06

Reproductive years

37.28 ± 4.88

35.62 ± 5.39

34.02 ± 4.93

Age of menarche

13.68 ± 1.52

13.59 ± 1.84

12.87 ± 1.97

Last menstrual period age*

47.6 ± 4.82

50.78 ± 5.00

50.32 ± 4.36

Number of pregnancies

1.95 ± 1.09

1.93 ± 1.14

1.99 ± 1.31

Years after menopause*

10.31 ± 5.78

12.37 ± 6.33

12.85 ± 6.04

BMD L2–L4 (g/cm²)

0.84 ± 0.06

0.084 ± 0.04

0.082 ± 0.06

BMD L2–L4 YA (%)*

59.93 ± 6.02

76.32 ± 6.90

70.23 ± 6.93

BMD L2–L4 AM (%)*

69.73 ± 6.82

74.56 ± 6.14

80.88 ± 7.33